Quintet Private Bank (Europe) S.A. Moderna, Inc. Transaction History
Quintet Private Bank (Europe) S.A.
- $1.78 Trillion
- Q3 2025
A detailed history of Quintet Private Bank (Europe) S.A. transactions in Moderna, Inc. stock. As of the latest transaction made, Quintet Private Bank (Europe) S.A. holds 302 shares of MRNA stock, worth $7,477. This represents 0.0% of its overall portfolio holdings.
Number of Shares
302
Previous 352
14.2%
Holding current value
$7,477
Previous $9.71 Million
19.68%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding MRNA
# of Institutions
847Shares Held
258MCall Options Held
40.2MPut Options Held
44M-
Vanguard Group Inc Valley Forge, PA41.2MShares$1.02 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$633 Million0.07% of portfolio
-
Baillie Gifford & CO21.8MShares$541 Million0.44% of portfolio
-
State Street Corp Boston, MA17.1MShares$424 Million0.02% of portfolio
-
Morgan Stanley New York, NY9.96MShares$247 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $9.69B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...